Sagility acquires CareSeed to accelerate AI-led quality operations and Medicare Advantage performance transformation
M&A
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 11 Jun 2026, 08:46 PM IST · BSE ID: 65f30644-ec3c-4e26-bd64-21e751e3e07e
View Original BSE Filing (PDF)
💡
In Simple Terms
Sagility acquired CareSeed, a US healthcare analytics company, for up to US$ 30 million to boost its service offerings.
🤖 AI Summary
- Sagility LLC, a step-down subsidiary, acquired 100% of CareSeed LLC for up to US$ 30 M cash.
- CareSeed, a USA healthcare analytics firm, reported US$ 5.1 M turnover for CY2025.
- The acquisition consideration includes an upfront payment of US$ 17.5 M at closing.
- Contingent consideration of up to US$ 12.5 M is payable based on revenue growth synergies.
- The acquisition enhances Sagility’s position in the payer ecosystem with HEDIS reporting and risk adjustment solutions.
🔢 Key Numbers — exact figures from BSE filing, not rounded
CareSeed Turnover (CY2025)
US$ 5.1M
CareSeed Turnover (CY2024)
US$ 4.0 M
CareSeed Turnover (CY2023)
US$ 3.6 M
Aggregate Purchase Consideration
US$ 30 M
Upfront Payment at Closing
US$ 17.5 M
Contingent Consideration
US$ 12.5 M
Percentage of Shareholding Acquired
100%
🏢 How This Affects the Company
This acquisition strengthens Sagility’s healthcare analytics capabilities, expanding its offerings into quality measurement (HEDIS) reporting and risk adjustment solutions. It adds a certified platform and a client base of 30 mid-sized U.S. health plans, enhancing Sagility’s presence in the payer ecosystem.
The acquisition involves a cash consideration of up to US$ 30 M, comprising an upfront payment of US$ 17.5 M and up to US$ 12.5 M in contingent consideration tied to revenue growth. This will impact Sagility's cash reserves and potentially future earnings through revenue synergies.
The acquisition integrates CareSeed's NCQA-certified HEDIS reporting platform and related value-added services into Sagility’s operations. It enables expansion into STAR performance management and care gap closure services, requiring integration of technologies and service delivery models.
The contingent consideration up to US$ 12.5 M linked to revenue growth synergies introduces a performance-based payment risk. Integration challenges associated with combining two healthcare analytics platforms and service teams could also emerge.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders.
👤
Who Is Affected
Shareholders are indirectly affected as Sagility's balance sheet will see a cash outflow of at least US$ 17.5 M for the upfront payment. The company's strategic direction is also impacted by the expanded service offerings.
🔍
Management Signal
This acquisition signals management's intent to strengthen its healthcare analytics and technology portfolio and expand its presence within the U.S. healthcare payer ecosystem.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q1 FY27 results — look for details on acquisition integration progress and financial impact.
Management commentary — check for updates on CareSeed's contribution to revenue growth and synergies.
Future filings — monitor for disclosures related to achievement of revenue growth targets for contingent payment.
MEDIUM RISK
Contingent consideration based on revenue growth introduces financial uncertainty; integration risks are inherent in M&A.
💡 Investor Takeaway
Sagility completed the acquisition of CareSeed LLC for an aggregate purchase consideration of up to US$ 30 M. This transaction strengthens Sagility's healthcare analytics capabilities with CareSeed's US$ 5.1 M (CY2025) turnover and NCQA-certified HEDIS reporting platform.
⚖️ Strengths & Concerns
✅ Positives
- Acquisition adds an NCQA-certified HEDIS reporting platform, enhancing Sagility's offerings in quality measurement and risk adjustment solutions.
- CareSeed’s presence with 30 mid-sized U.S. health plans strengthens Sagility’s market position in the payer ecosystem.
⚠️ Concerns
- The aggregate purchase consideration of up to US$ 30 M includes a contingent component of US$ 12.5 M tied to future revenue growth, introducing performance-based payment uncertainty.
- CareSeed’s turnover of US$ 5.1 M in CY2025 is relatively modest compared to the maximum acquisition cost of US$ 30 M, indicating a high valuation multiple.
📅 Company Track Record
Sagility Limited was incorporated in 2021 (CIN: L72900KA2021PLC150054). No previous filings containing financial performance or order book details were found for this company to establish a historical trend.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the total acquisition cost for Sagility's purchase of CareSeed?
Sagility's step-down subsidiary acquired CareSeed LLC for an aggregate purchase consideration of up to US$ 30 M.
What is the upfront payment for the CareSeed acquisition?
The upfront payment at closing for the CareSeed acquisition is US$ 17.5 M, subject to customary closing adjustments.
What was CareSeed's turnover in CY2025?
CareSeed LLC reported a turnover of US$ 5.1 M for Calendar Year 2025.
What percentage of CareSeed LLC did Sagility acquire?
Sagility LLC acquired 100% shareholding and control of CareSeed LLC.
What is the purpose of Sagility's acquisition of CareSeed?
The acquisition aligns with Sagility’s strategy to strengthen its healthcare analytics capabilities and expand into quality measurement and risk adjustment solutions, enhancing its position in the payer ecosystem.
Questions based on this BSE filing only. For information purposes.